The soluble glutathione transferase superfamily: role of Mu class in triclabendazole sulphoxide challenge in Fasciola hepatica.
Affinity chromatography
Anthelmintic
Glutathione transferases
Proteomics
Journal
Parasitology research
ISSN: 1432-1955
Titre abrégé: Parasitol Res
Pays: Germany
ID NLM: 8703571
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
27
08
2020
accepted:
12
01
2021
pubmed:
28
1
2021
medline:
29
4
2021
entrez:
27
1
2021
Statut:
ppublish
Résumé
Fasciola hepatica (liver fluke), a significant threat to food security, causes global economic loss for the livestock industry and is re-emerging as a foodborne disease of humans. In the absence of vaccines, treatment control is by anthelmintics; with only triclabendazole (TCBZ) currently effective against all stages of F. hepatica in livestock and humans. There is widespread resistance to TCBZ and its detoxification by flukes might contribute to the mechanism. However, there is limited phase I capacity in adult parasitic helminths with the phase II detoxification system dominated by the soluble glutathione transferase (GST) superfamily. Previous proteomic studies have demonstrated that the levels of Mu class GST from pooled F. hepatica parasites respond under TCBZ-sulphoxide (TCBZ-SO) challenge during in vitro culture ex-host. We have extended this finding by exploiting a sub-proteomic lead strategy to measure the change in the total soluble GST profile (GST-ome) of individual TCBZ-susceptible F. hepatica on TCBZ-SO-exposure in vitro culture. TCBZ-SO exposure demonstrated differential abundance of FhGST-Mu29 and FhGST-Mu26 following affinity purification using both GSH and S-hexyl GSH affinity. Furthermore, a low or weak affinity matrix interacting Mu class GST (FhGST-Mu5) has been identified and recombinantly expressed and represents a new low-affinity Mu class GST. Low-affinity GST isoforms within the GST-ome was not restricted to FhGST-Mu5 with a second likely low-affinity sigma class GST (FhGST-S2) uncovered. This study represents the most complete Fasciola GST-ome generated to date and has supported the potential of subproteomic analyses on individual adult flukes.
Identifiants
pubmed: 33501588
doi: 10.1007/s00436-021-07055-5
pii: 10.1007/s00436-021-07055-5
pmc: PMC7889535
doi:
Substances chimiques
Anthelmintics
0
Helminth Proteins
0
Isoenzymes
0
Sulfoxides
0
Triclabendazole
4784C8E03O
Glutathione Transferase
EC 2.5.1.18
triclabendazole sulfoxide
KY3O5E011U
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
979-991Subventions
Organisme : Innovate UK
ID : 102108
Références
ACS Omega. 2020 May 06;5(19):11084-11091
pubmed: 32455229
Mol Cell Proteomics. 2018 Apr;17(4):792-809
pubmed: 29321187
Mol Biochem Parasitol. 2016 Mar-Apr;206(1-2):46-55
pubmed: 26792248
Mol Biol Evol. 2007 Aug;24(8):1596-9
pubmed: 17488738
Parasitology. 2005 Oct;131(Pt 4):501-10
pubmed: 16174415
PLoS Negl Trop Dis. 2011 Jan 04;5(1):e937
pubmed: 21245911
Mol Biochem Parasitol. 2012 Jan;181(1):37-9
pubmed: 22001370
Nucleic Acids Res. 2019 Jan 8;47(D1):D427-D432
pubmed: 30357350
Bioinformatics. 2007 Jan 15;23(2):262-3
pubmed: 17121776
J Egypt Soc Parasitol. 2009 Apr;39(1):73-83
pubmed: 19530611
PLoS Negl Trop Dis. 2012;6(5):e1666
pubmed: 22666515
J Proteome Res. 2010 Oct 1;9(10):4940-51
pubmed: 20726552
Proteomics. 2006 Dec;6(23):6263-73
pubmed: 17078019
Genome Biol. 2015 Apr 03;16:71
pubmed: 25887684
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Oncogene. 2003 Oct 20;22(47):7369-75
pubmed: 14576844
Mol Biochem Parasitol. 1990 Mar;39(2):155-61
pubmed: 2320055
Exp Mol Pathol. 2007 Apr;82(2):104-9
pubmed: 17398281
Methods Enzymol. 2005;401:1-8
pubmed: 16399376
J Proteome Res. 2012 Dec 7;11(12):5876-89
pubmed: 23167294
Vet Parasitol. 2009 Oct 14;164(2-4):211-6
pubmed: 19560276
Mol Neurodegener. 2012 Apr 11;7:13
pubmed: 22494505
Mol Biochem Parasitol. 1995 Feb;69(2):281-8
pubmed: 7770091
PLoS Negl Trop Dis. 2011 Feb 01;5(2):e1004
pubmed: 21408104
Acta Trop. 2008 Feb;105(2):99-112
pubmed: 17897613
PLoS Genet. 2017 Jan 6;13(1):e1006537
pubmed: 28060841
Drug Metab Rev. 2011 May;43(2):226-35
pubmed: 21495794
Vet Parasitol. 2010 Apr 19;169(1-2):62-75
pubmed: 20089359
Sci Rep. 2017 Dec 13;7(1):17547
pubmed: 29235505
Biotechnol Adv. 2010 Mar-Apr;28(2):222-31
pubmed: 20006979
Mol Biol Evol. 2020 Jan 1;37(1):84-99
pubmed: 31501870
J Biol Chem. 1974 Nov 25;249(22):7130-9
pubmed: 4436300
Vet Rec. 2000 Feb 12;146(7):200
pubmed: 10718597
Crit Rev Biochem Mol Biol. 1995;30(6):445-600
pubmed: 8770536
Drug Metab Rev. 2009;41(1):8-26
pubmed: 19514969
Parasitology. 2012 Aug;139(9):1205-17
pubmed: 22776506
Exp Parasitol. 2015 Dec;159:274-9
pubmed: 26542261